Our research projects
To tackle these diseases we need to see research into a range of therapeutic approaches, giving us the best chance of finding effective treatments sooner.
This study is looking to find out whether the immune system is altered in dementia with Lewy bodies compared to Alzheimer’s disease and healthy volunteers.
The Dementia Consortium was set up to fund target validation – an important step on the road from laboratory to treatments in the clinic.
Alzheimer’s Research UK Research Fellow Tim Shakespeare explains how research into how eye movements are affected by posterior cortical atrophy (PCA).
People with FTD typically experience changes in personality, emotions and decision making; all symptoms that can be confused for other conditions.
There has been lots of discussion, both within the popular press and the research community, about the importance of early detection and diagnosis of the diseases that cause dementia.
In several forms of dementia, including Alzheimer’s, frontotemporal dementia, corticobasal degeneration and progressive supranuclear palsy, tau starts to behave out of character.
While inflammation can protect the body, too much of a good thing can have its consequences.
Amyloid has long been a key focus of Alzheimer’s research, but as today’s session showed, scientists are still discovering more about it all the time.
The meeting is the largest dementia research conference in the UK and scientists from across our Research Network will be joined by international dementia experts; a global approach to this global medical challenge.